metoprolol has been researched along with Recrudescence in 69 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Consecutive outpatients with persistent atrial fibrillation (AF) were randomized to treatment with metoprolol CR or placebo in a double-blind fashion." | 9.12 | Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. ( Frick, M; Nergårdh, AK; Nordlander, R; Rosenqvist, M, 2007) |
| "To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI IIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group)." | 9.07 | Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. ( Babb, JD; Baim, DS; Braunwald, E; Chesebro, JH; Frederick, M; Gore, JM; Passamani, ER; Roberts, R; Rogers, WJ; Williams, DO, 1991) |
| "The Stockholm Metoprolol Trial is a prospective double-blind placebo-controlled postmyocardial infarction study of 301 patients treated with metoprolol, 100 mg b." | 9.06 | Reduction of nonfatal reinfarctions in patients with a history of hypertension by chronic postinfarction treatment with metoprolol. ( Olsson, G; Rehnqvist, N, 1986) |
| "The mortality and morbidity were assessed during a 2-year follow-up in an acute intervention trial in suspected acute myocardial infarction with metoprolol (a selective beta 1-blocker)." | 9.06 | The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assessed in the Göteborg metoprolol trial. ( Herlitz, J; Hjalmarson, A; Swedberg, K; Vedin, A; Waagstein, F; Waldenström, A; Wilhelmsson, C, 1986) |
| "In 1,395 patients in the age range 40-74 years participating in a double-blind trial with metoprolol in suspected acute myocardial infarction morbidity and quality of life were assessed during the first 5 years after randomization." | 9.06 | Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction. ( Bengtson, A; Herlitz, J; Hjalmarson, A; Wiklund, I, 1988) |
| "The effect of metoprolol on the development of an acute myocardial infarction (AMI) during days 0 to 3 and on late first and recurrent infarctions during days 4 to 15 has been investigated." | 9.05 | Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group. ( , 1985) |
| "The effects of metoprolol treatment in patients surviving acute myocardial infarction have been investigated in a double-blind randomized study." | 9.05 | Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. ( Erhardt, L; Lundman, T; Olsson, G; Rehnqvist, N; Sjögren, A, 1985) |
| " To unmask the potential risk of Tdp in a patient with normal or borderline prolongation of QTc interval and recurrent syncope, dobutamine was given intravenously at a rate of 20 microg/kg/min." | 7.75 | Dobutamine infusion for unmasking long QT syndrome and torsades de pointes. ( Cuilan, L; Dayi, H; Kangan, C; Peng, G; Quan, F; Richard, CC, 2009) |
| "One hundred thirty-one patients presenting with acute myocardial infarction (AMI) a mean of 3 hours after the onset of symptoms were treated with oral aspirin and intravenous thrombolytic therapy followed by heparin." | 7.68 | Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction. ( Commerford, PJ; Gordon, GD; Green, BK; Horak, AR; Millar, RN, 1992) |
| "Primary endpoint was symptomatic recurrence over 1-year follow-up." | 6.82 | Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation. ( Capucci, A; Gabrielli, D; Guerra, F; Piangerelli, L; Ricciotti, J, 2016) |
| "Metoprolol is a β-adrenergic receptor antagonist that is ineffective in younger patients, but may benefit older (≥40 years) VVS patients." | 6.82 | Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5). ( Benditt, DG; Faris, PD; Krahn, AD; Manns, B; Morillo, CA; Raj, SR; Semeniuk, L; Sheldon, RS, 2016) |
| "The high early recurrence (ER) rate after radiofrequency catheter ablation (RFCA) seriously affects the prognosis of patients with atrial fibrillation (AF), and there are still controversies regarding the best preventive drugs for postoperative recurrence." | 5.72 | Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis. ( Peng, Y; Wang, P; Yan, D; Zhang, Z, 2022) |
| "Recurrence was noted to occur within 2 months of therapy." | 5.46 | Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. ( Ermakov, S; Gerstenfeld, EP; Scheinman, MM; Svetlichnaya, Y, 2017) |
| " There were no significant differences in the secondary endpoints of recurrent angina, readmission, and tachyarrhythmias except for more first- and second-degree AV blocks with metoprolol (12." | 5.24 | Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine". ( Bisht, DS; Gokhroo, RK; Gupta, S; Kishore, K; Priti, K; Ranwa, BL, 2017) |
| "Consecutive outpatients with persistent atrial fibrillation (AF) were randomized to treatment with metoprolol CR or placebo in a double-blind fashion." | 5.12 | Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. ( Frick, M; Nergårdh, AK; Nordlander, R; Rosenqvist, M, 2007) |
| "Determination of neurophysiological features of the disease course in patients with paroxysmal atrial fibrillation (AF); pathogenetic validation of use and assessment of therapeutic efficacy of clonazepam (an atypical agonist of benzodiazepine receptors) in combined antiarrhythmic therapy." | 5.12 | [New facts about pathogenesis of atrial fibrillation: correlation between changes in bioelectric brain activity and recurrence of atrial fibrillation paroxysms]. ( Fedorova, VI; Gordeev, SA; Nedostup, AV; Vasiukov, SS, 2007) |
| "To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI IIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group)." | 5.07 | Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. ( Babb, JD; Baim, DS; Braunwald, E; Chesebro, JH; Frederick, M; Gore, JM; Passamani, ER; Roberts, R; Rogers, WJ; Williams, DO, 1991) |
| " Patients whose arrhythmia was inducible by programmed electrical stimulation were assigned to treatment with electrophysiologically guided drug therapy based on serial testing (61 patients) or with metoprolol (54 patients)." | 5.07 | A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. ( Andresen, D; Bach, P; Haberl, R; Hoffmann, E; Oeff, M; Steinbeck, G; von Leitner, ER, 1992) |
| "From a randomized multicenter trial with metoprolol in suspected acute myocardial infarction (n = 5778) we report on the outcome during a one-year follow-up in patients with confirmed infarction (n = 4106) in relation to whether or not they developed Q waves." | 5.06 | Prognosis during one year for patients with myocardial infarction in relation to the development of Q waves: experiences from the Miami trial. ( Herlitz, J; Hjalmarson, A; Karlson, BW, 1990) |
| "From a large randomized multicentre trial of metoprolol in suspected acute myocardial infarction (n = 5778) we report on the outcome during 1 year of follow-up, in relation to early diagnosis." | 5.06 | Mortality and morbidity during one year of follow-up in suspected acute myocardial infarction in relation to early diagnosis: experiences from the MIAMI trial. ( Herlitz, J; Hjalmarson, A; Karlson, BW, 1990) |
| "In 1,395 patients in the age range 40-74 years participating in a double-blind trial with metoprolol in suspected acute myocardial infarction morbidity and quality of life were assessed during the first 5 years after randomization." | 5.06 | Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction. ( Bengtson, A; Herlitz, J; Hjalmarson, A; Wiklund, I, 1988) |
| "In a double-blind randomized study of 154 postmyocardial infarction patients assigned to metoprolol (100 mg twice daily) and 147 patients assigned placebo, the outcome during a 3-year follow-up according to serum cholesterol concentrations was evaluated." | 5.06 | Postinfarction metoprolol treatment: effects on prognosis in relation to serum cholesterol concentrations. ( Olsson, G; Rehnqvist, N, 1987) |
| "The mortality and morbidity were assessed during a 2-year follow-up in an acute intervention trial in suspected acute myocardial infarction with metoprolol (a selective beta 1-blocker)." | 5.06 | The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assessed in the Göteborg metoprolol trial. ( Herlitz, J; Hjalmarson, A; Swedberg, K; Vedin, A; Waagstein, F; Waldenström, A; Wilhelmsson, C, 1986) |
| "The Stockholm Metoprolol Trial is a prospective double-blind placebo-controlled postmyocardial infarction study of 301 patients treated with metoprolol, 100 mg b." | 5.06 | Reduction of nonfatal reinfarctions in patients with a history of hypertension by chronic postinfarction treatment with metoprolol. ( Olsson, G; Rehnqvist, N, 1986) |
| "The effects of metoprolol treatment in patients surviving acute myocardial infarction have been investigated in a double-blind randomized study." | 5.05 | Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity. ( Erhardt, L; Lundman, T; Olsson, G; Rehnqvist, N; Sjögren, A, 1985) |
| "The effect of metoprolol on the development of an acute myocardial infarction (AMI) during days 0 to 3 and on late first and recurrent infarctions during days 4 to 15 has been investigated." | 5.05 | Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group. ( , 1985) |
| " To unmask the potential risk of Tdp in a patient with normal or borderline prolongation of QTc interval and recurrent syncope, dobutamine was given intravenously at a rate of 20 microg/kg/min." | 3.75 | Dobutamine infusion for unmasking long QT syndrome and torsades de pointes. ( Cuilan, L; Dayi, H; Kangan, C; Peng, G; Quan, F; Richard, CC, 2009) |
| "Seventy consecutive patients with recurrent unexplained syncope were evaluated by use of an up-right tilt-table test for 45 minutes (with or without an infusion of isoproterenol) in an attempt to reproduce symptoms." | 3.68 | [Malignant vasovagal syncope: its diagnosis and therapeutic trial based on the orthostatism test (the tilt-table test)]. ( Campos Peris, JV; de la Morena, G; García García, J; Jaén Armand, E; López Candel, J; Martínez Sánchez, J; Picó Aracil, F; Ruiz Ros, JA; Salas, J; Sánchez Muñoz, JJ, 1993) |
| "One hundred thirty-one patients presenting with acute myocardial infarction (AMI) a mean of 3 hours after the onset of symptoms were treated with oral aspirin and intravenous thrombolytic therapy followed by heparin." | 3.68 | Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction. ( Commerford, PJ; Gordon, GD; Green, BK; Horak, AR; Millar, RN, 1992) |
| "We present a case treated with aprindine and metoprolol combined with a DDD type pacemaker for repetitive monomorphic ventricular tachycardia." | 3.68 | [A case of repetitive monomorphic ventricular tachycardia]. ( Komatsu, C; Kubouchi, Y; Kudou, S; Kurusu, O; Nomoto, J; Okamura, T; Sanada, T; Tanoiri, T; Tokuhisa, Y, 1992) |
| "Primary endpoint was symptomatic recurrence over 1-year follow-up." | 2.82 | Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation. ( Capucci, A; Gabrielli, D; Guerra, F; Piangerelli, L; Ricciotti, J, 2016) |
| "Metoprolol is a β-adrenergic receptor antagonist that is ineffective in younger patients, but may benefit older (≥40 years) VVS patients." | 2.82 | Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5). ( Benditt, DG; Faris, PD; Krahn, AD; Manns, B; Morillo, CA; Raj, SR; Semeniuk, L; Sheldon, RS, 2016) |
| "Metoprolol was not effective in preventing vasovagal syncope in the study population." | 2.72 | Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. ( Connolly, S; Fouad-Tarazi, F; Klingenheben, T; Koshman, ML; Krahn, A; Ku, T; Morillo, C; Ritchie, D; Rose, S; Sheldon, R; Talajic, M, 2006) |
| "Few therapies for vasovagal syncope have been proven effective." | 2.71 | Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design. ( Connolly, S; Rose, S; Sheldon, R, 2003) |
| "The treatment of migraine takes into consideration the intensity of the headache and the accompanying symptoms." | 2.42 | [Treatment and prophylaxis of an acute migraine attack]. ( Diener, HC; Gendolla, A, 2004) |
| "The high early recurrence (ER) rate after radiofrequency catheter ablation (RFCA) seriously affects the prognosis of patients with atrial fibrillation (AF), and there are still controversies regarding the best preventive drugs for postoperative recurrence." | 1.72 | Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis. ( Peng, Y; Wang, P; Yan, D; Zhang, Z, 2022) |
| "Recurrence was noted to occur within 2 months of therapy." | 1.46 | Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. ( Ermakov, S; Gerstenfeld, EP; Scheinman, MM; Svetlichnaya, Y, 2017) |
| "Recurrent life-threatening episodes of ventricular tachycardia persisted despite maximal antiarrhythmic theraphy with amiodarone, metoprolol and mexiletine." | 1.33 | Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. ( Anastasiou-Nana, MI; Kanakakis, J; Rokas, S; Tsagalou, EP, 2005) |
| "Pharmacological therapy of neurocardiogenic syncope is often limited by the relatively low response rate to such treatment." | 1.30 | Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers. ( Credner, S; Hohnloser, SH; Klingenheben, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (26.09) | 18.7374 |
| 1990's | 22 (31.88) | 18.2507 |
| 2000's | 14 (20.29) | 29.6817 |
| 2010's | 10 (14.49) | 24.3611 |
| 2020's | 5 (7.25) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, P | 1 |
| Yan, D | 1 |
| Peng, Y | 1 |
| Zhang, Z | 1 |
| Deveau, AP | 1 |
| Sheldon, R | 3 |
| Maxey, C | 1 |
| Ritchie, D | 2 |
| Doucette, S | 1 |
| Parkash, R | 1 |
| Sahu, KK | 1 |
| Mishra, AK | 1 |
| Doshi, A | 1 |
| Martin, KB | 1 |
| Chuzi, S | 1 |
| Eucalitto, P | 1 |
| Yee, LM | 1 |
| Zhang, JG | 1 |
| Dai, SP | 1 |
| Liu, H | 1 |
| Xu, ZS | 1 |
| Priti, K | 1 |
| Ranwa, BL | 1 |
| Gokhroo, RK | 1 |
| Kishore, K | 1 |
| Bisht, DS | 1 |
| Gupta, S | 1 |
| Olberg, HK | 1 |
| Odland, HH | 1 |
| Kask, A | 1 |
| Engelsen, BA | 1 |
| Fonarow, G | 1 |
| Tsang, MY | 1 |
| Calvin, AD | 1 |
| Reeder, GS | 1 |
| Ammash, NM | 1 |
| Hammack, JE | 1 |
| Melduni, RM | 1 |
| Tagawa, M | 1 |
| Ochiai, S | 1 |
| Nakamura, Y | 1 |
| Sato, A | 1 |
| Chinushi, M | 1 |
| Capucci, A | 1 |
| Piangerelli, L | 1 |
| Ricciotti, J | 1 |
| Gabrielli, D | 1 |
| Guerra, F | 1 |
| Raj, SR | 1 |
| Faris, PD | 1 |
| Semeniuk, L | 1 |
| Manns, B | 1 |
| Krahn, AD | 1 |
| Morillo, CA | 1 |
| Benditt, DG | 1 |
| Sheldon, RS | 1 |
| Ermakov, S | 1 |
| Gerstenfeld, EP | 1 |
| Svetlichnaya, Y | 1 |
| Scheinman, MM | 1 |
| Andersen, SS | 1 |
| Hansen, ML | 1 |
| Gislason, GH | 1 |
| Folke, F | 1 |
| Schramm, TK | 1 |
| Fosbøl, E | 1 |
| Sørensen, R | 1 |
| Rasmussen, S | 1 |
| Abildstrøm, SZ | 1 |
| Madsen, M | 1 |
| Køber, L | 1 |
| Torp-Pedersen, C | 1 |
| Quan, F | 1 |
| Peng, G | 1 |
| Kangan, C | 1 |
| Dayi, H | 1 |
| Cuilan, L | 1 |
| Richard, CC | 1 |
| Solov'ev, OV | 1 |
| Efremov, DN | 1 |
| Onuchina, EL | 1 |
| Solov'eva, NV | 1 |
| Kononov, SV | 1 |
| Venkataraman, G | 1 |
| Strickberger, SA | 1 |
| Tchan, M | 1 |
| Sillence, D | 1 |
| Kettering, K | 1 |
| Mewis, C | 1 |
| Dörnberger, V | 1 |
| Vonthein, R | 1 |
| Bosch, RF | 1 |
| Kühlkamp, V | 1 |
| Rose, S | 2 |
| Connolly, S | 2 |
| Alegria, JR | 1 |
| Gersh, BJ | 1 |
| Scott, CG | 1 |
| Hodge, DO | 1 |
| Hammill, SC | 1 |
| Shen, WK | 1 |
| Ruzyllo, W | 1 |
| Szwed, H | 1 |
| Sadowski, Z | 1 |
| Elikowski, W | 1 |
| Grzelak-Szafranska, H | 1 |
| Orszulak, W | 1 |
| Szymczak, K | 1 |
| Winter, M | 1 |
| Hammersen, F | 1 |
| Lübcke, N | 1 |
| Lüders, S | 1 |
| Diener, HC | 2 |
| Schrader, J | 1 |
| Gendolla, A | 1 |
| Tsagalou, EP | 1 |
| Kanakakis, J | 1 |
| Rokas, S | 1 |
| Anastasiou-Nana, MI | 1 |
| Klingenheben, T | 2 |
| Krahn, A | 1 |
| Morillo, C | 1 |
| Talajic, M | 1 |
| Ku, T | 1 |
| Fouad-Tarazi, F | 1 |
| Koshman, ML | 1 |
| Nergårdh, AK | 1 |
| Rosenqvist, M | 1 |
| Nordlander, R | 1 |
| Frick, M | 1 |
| Nedostup, AV | 1 |
| Vasiukov, SS | 1 |
| Fedorova, VI | 1 |
| Gordeev, SA | 1 |
| Moser, M | 1 |
| Gorlin, R | 1 |
| Staessen, J | 1 |
| Bulpitt, C | 1 |
| Cattaert, A | 1 |
| Fagard, R | 1 |
| Vanhees, L | 1 |
| Amery, A | 1 |
| Vacheron, A | 1 |
| Baubion, N | 1 |
| Delage, F | 1 |
| Rotmensch, HH | 1 |
| Vlasses, PH | 1 |
| Ferguson, RK | 1 |
| Gillis, AM | 1 |
| Clusin, WT | 1 |
| Khan, AH | 1 |
| Rizos, I | 1 |
| Senges, J | 1 |
| Jauernig, R | 1 |
| Lengfelder, W | 1 |
| Czygan, E | 1 |
| Brachmann, J | 1 |
| Kübler, W | 1 |
| Park, KC | 1 |
| Forman, DE | 1 |
| Wei, JY | 1 |
| Osterziel, KJ | 1 |
| Siebels, J | 1 |
| Cappato, R | 1 |
| Rüppel, R | 1 |
| Schneider, MA | 1 |
| Kuck, KH | 1 |
| López Candel, J | 1 |
| Picó Aracil, F | 1 |
| Sánchez Muñoz, JJ | 1 |
| de la Morena, G | 1 |
| Martínez Sánchez, J | 1 |
| Salas, J | 1 |
| Campos Peris, JV | 1 |
| Ruiz Ros, JA | 1 |
| García García, J | 1 |
| Jaén Armand, E | 1 |
| Sra, JS | 1 |
| Jazayeri, MR | 1 |
| Avitall, B | 1 |
| Dhala, A | 2 |
| Deshpande, S | 1 |
| Blanck, Z | 1 |
| Akhtar, M | 2 |
| Jhamb, DK | 1 |
| Singh, B | 1 |
| Sharda, B | 1 |
| Kaul, U | 1 |
| Goel, P | 1 |
| Talwar, KK | 1 |
| Wasir, HS | 1 |
| Natale, A | 1 |
| Newby, KH | 1 |
| Sra, J | 1 |
| Deal, BJ | 1 |
| Strieper, M | 1 |
| Scagliotti, D | 1 |
| Hulse, E | 1 |
| Auld, D | 1 |
| Campbell, R | 1 |
| Strasburger, JF | 1 |
| Benson, DW | 1 |
| Hirata, K | 1 |
| Takagi, Y | 1 |
| Nakada, M | 1 |
| Kyushima, M | 1 |
| Asato, H | 1 |
| Fries, R | 1 |
| Heisel, A | 1 |
| Schieffer, H | 1 |
| Ludman, PF | 1 |
| Credner, S | 1 |
| Hohnloser, SH | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Kasper, W | 1 |
| Kersting, F | 1 |
| Breuing, KH | 1 |
| Steinbeck, G | 1 |
| Andresen, D | 1 |
| Bach, P | 1 |
| Haberl, R | 1 |
| Oeff, M | 1 |
| Hoffmann, E | 1 |
| von Leitner, ER | 1 |
| Ruocco, NA | 1 |
| Bergelson, BA | 1 |
| Jacobs, AK | 1 |
| Frederick, MM | 1 |
| Faxon, DP | 1 |
| Ryan, TJ | 1 |
| Kurusu, O | 1 |
| Kudou, S | 1 |
| Nomoto, J | 1 |
| Tanoiri, T | 1 |
| Tokuhisa, Y | 1 |
| Kubouchi, Y | 1 |
| Sanada, T | 1 |
| Komatsu, C | 1 |
| Okamura, T | 1 |
| Green, BK | 1 |
| Gordon, GD | 1 |
| Horak, AR | 1 |
| Millar, RN | 1 |
| Commerford, PJ | 1 |
| Rogers, WJ | 1 |
| Babb, JD | 1 |
| Baim, DS | 1 |
| Chesebro, JH | 1 |
| Gore, JM | 1 |
| Roberts, R | 1 |
| Williams, DO | 1 |
| Frederick, M | 1 |
| Passamani, ER | 1 |
| Braunwald, E | 1 |
| Herlitz, J | 5 |
| Hjalmarson, A | 5 |
| Karlson, BW | 3 |
| Grotemeyer, KH | 1 |
| Scharafinski, HW | 1 |
| Schlake, HP | 1 |
| Husstedt, IW | 1 |
| Stäblein, A | 1 |
| Huber, I | 1 |
| von Scheidt, W | 1 |
| Bengtson, A | 2 |
| Wiklund, I | 1 |
| Olsson, G | 4 |
| Rehnqvist, N | 4 |
| Swedberg, K | 1 |
| Vedin, A | 1 |
| Waagstein, F | 1 |
| Waldenström, A | 1 |
| Wilhelmsson, C | 1 |
| Levin, LA | 1 |
| Sjögren, A | 1 |
| Erhardt, L | 1 |
| Lundman, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Single Site, Interventional, Comparative Study to Evaluate the Safety and Efficacy of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences[NCT03162120] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2018-09-01 | Withdrawn (stopped due to new study type, it will be re-organiZed as an Investigator Initiated Study (IIS)) | ||
| Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects[NCT02123056] | Phase 4 | 52 participants (Actual) | Interventional | 2014-10-31 | Active, not recruiting | ||
| Pilot Randomized Trial With Flecainide in ARVC Patients[NCT03685149] | Phase 2 | 23 participants (Actual) | Interventional | 2019-07-31 | Completed | ||
| [NCT00000505] | Phase 3 | 0 participants | Interventional | 1983-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for metoprolol and Recrudescence
| Article | Year |
|---|---|
[Treatment and prophylaxis of an acute migraine attack].
Topics: Acupuncture Therapy; Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Analgesics; A | 2004 |
The role of beta-adrenergic receptor antagonists in the prevention of sudden cardiac death.
Topics: Action Potentials; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium; Calcium Channel Block | 1984 |
32 trials available for metoprolol and Recrudescence
| Article | Year |
|---|---|
Sex Differences in Vasovagal Syncope: A Post Hoc Analysis of the Prevention of Syncope Trials (POST) I and II.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Canada; Electrocardiography; Fem | 2020 |
Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Block; Benzazepines | 2017 |
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiography; F | 2016 |
Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Aging; Dose-Response Relationship, D | 2016 |
Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
Topics: Defibrillators, Implantable; Female; Humans; Male; Metoprolol; Middle Aged; Prospective Studies; Rec | 2002 |
Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Humans; Metoprolol; Middle Aged; Prospective Studies; Qual | 2003 |
Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Bypass | 2004 |
Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Double-Blind Method; Female; Humans; Incidence; Mal | 2006 |
Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Double-Blind Method; E | 2007 |
[New facts about pathogenesis of atrial fibrillation: correlation between changes in bioelectric brain activity and recurrence of atrial fibrillation paroxysms].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Atrial Fibrillation; Beta Rhythm; Brain; Clonaz | 2007 |
Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1982 |
beta-Blockers and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Diuretic | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myoc | 1982 |
Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Death, Sudden; Humans; Metoprolol; Myocardial | 1984 |
Beta-adrenoreceptor blocking agents. Their role in reducing chances of recurrent infarction and death.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Inf | 1983 |
Utility of beta-blockade treatment for older postinfarction patients.
Topics: Age Factors; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Logistic Models; Male; Meto | 1995 |
ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable | 1993 |
Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Artery Bypass | 1995 |
Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response.
Topics: Adolescent; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Female; Heart | 1996 |
A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; E | 1992 |
Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II).
Topics: Administration, Oral; Aged; Angina Pectoris; Cardiac Catheterization; Combined Modality Therapy; Cor | 1992 |
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
Topics: Aged; Aspirin; Coronary Angiography; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Co | 1991 |
Prognosis during one year for patients with myocardial infarction in relation to the development of Q waves: experiences from the Miami trial.
Topics: Electrocardiography; Female; Follow-Up Studies; Humans; Male; Metoprolol; Middle Aged; Multicenter S | 1990 |
Mortality and morbidity during one year of follow-up in suspected acute myocardial infarction in relation to early diagnosis: experiences from the MIAMI trial.
Topics: Angina Pectoris; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incide | 1990 |
Acetylsalicylic acid vs. metoprolol in migraine prophylaxis--a double-blind cross-over study.
Topics: Adult; Aspirin; Double-Blind Method; Female; Humans; Male; Metoprolol; Migraine Disorders; Recurrenc | 1990 |
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Meto
Topics: Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Care Units; Double-Blind | 1986 |
Morbidity and quality of life 5 years after early intervention with metoprolol in suspected acute myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Female; Follow-Up S | 1988 |
Postinfarction metoprolol treatment: effects on prognosis in relation to serum cholesterol concentrations.
Topics: Cholesterol; Double-Blind Method; Female; Humans; Male; Metoprolol; Myocardial Infarction; Placebos; | 1987 |
The influence of early intervention in acute myocardial infarction on long-term mortality and morbidity as assessed in the Göteborg metoprolol trial.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Disability Evaluation; Follow-Up Studies; Hu | 1986 |
Reduction of nonfatal reinfarctions in patients with a history of hypertension by chronic postinfarction treatment with metoprolol.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Male | 1986 |
Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cerebrovascular Disorders; Clinical Trials as Topic; Co | 1985 |
Metoprolol in acute myocardial infarction. Development of myocardial infarction. The MIAMI Trial Research Group.
Topics: Clinical Trials as Topic; Electrocardiography; Humans; Metoprolol; Myocardial Infarction; Recurrence | 1985 |
35 other studies available for metoprolol and Recrudescence
| Article | Year |
|---|---|
Efficacy and Safety of Sustained-Release Metoprolol With Dronedarone After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation: A Propensity Matched Analysis.
Topics: Atrial Fibrillation; Catheter Ablation; Delayed-Action Preparations; Dronedarone; Humans; Metoprolol | 2022 |
Heart broken twice: a case of recurrent Takatsubo cardiomyopathy.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Echocardiography; Female; Humans; Lisinopril; Meto | 2020 |
A Pregnant Woman With Shortness of Breath.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Anticoagulants; Cesarean Section; Dyspnea; Echocardio | 2021 |
Comparison of carvedilol versus metoprolol in patients with acute myocardial infarction: A protocol for systematic review and meta-analysis.
Topics: Arrhythmias, Cardiac; Carvedilol; Death, Sudden, Cardiac; Humans; Meta-Analysis as Topic; Metoprolol | 2021 |
A woman in her thirties with seizure relapse after a previous diagnosis of epilepsy.
Topics: Adult; Anti-Arrhythmia Agents; Epilepsy; ERG1 Potassium Channel; Female; Humans; Long QT Syndrome; M | 2018 |
Update on pharmacological advances.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Disea | 2004 |
New-onset chest pain and palpitation. Coronary embolism.
Topics: Aged; Atrial Fibrillation; Chest Pain; Coronary Angiography; Coronary Thrombosis; Echocardiography, | 2014 |
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.
Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Bacterial Agents; Electrocar | 2016 |
[Anti-angina fixed combination is available].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Cardiovascular Agents; Combined Modal | 2016 |
Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter Ablation; Combin | 2017 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male | 2009 |
Dobutamine infusion for unmasking long QT syndrome and torsades de pointes.
Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Defibrillators, Implantable; DNA Mutational Analys | 2009 |
[The use of metoprolol tartrate during restoration of sinus rhythm and its subsequent maintenance in patients with chronic atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; | 2009 |
Atrial fibrillation degenerates into ventricular fibrillation.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Defibrillators, Impla | 2010 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defib | 2011 |
Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Comorbidity; Female; Humans; Male; Metoprolol; M | 2003 |
[Recurrent hemispheric symptoms without proof of ischemia].
Topics: Acetazolamide; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Diagnosis, Differential; | 2004 |
Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillator | 2005 |
[Secondary prevention of myocardial infarct with beta blockers].
Topics: Adrenergic beta-Antagonists; Coronary Circulation; Coronary Disease; Humans; Metoprolol; Myocardial | 1983 |
Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia.
Topics: Adult; Aged; Atrioventricular Node; Female; Humans; Male; Metoprolol; Middle Aged; Recurrence; Sotal | 1984 |
[Beta-receptor blockers after revascularization in coronary sclerosis].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Diseas | 1995 |
[Malignant vasovagal syncope: its diagnosis and therapeutic trial based on the orthostatism test (the tilt-table test)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Clonidine; Female; Heart Functio | 1993 |
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Topics: Adolescent; Adult; Aged; Bradycardia; Cardiac Pacing, Artificial; Disopyramide; Female; Follow-Up St | 1993 |
Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Electrocardiography; Female; Follow-Up | 1996 |
The medical therapy of cardioinhibitory syncope in pediatric patients.
Topics: Adrenergic Agonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Child; Cohort Studies; Disopy | 1997 |
Beat-to-beat variation of the ST segment in a patient with right bundle branch block, persistent ST segment elevation, and ventricular fibrillation: a case report.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Electric Countershock; Electrocardiography; Hear | 1998 |
Influence of beta-blockers on the frequency of arrhythmia recurrences in patients with implantable cardioverter-defibrillator: an intraindividual comparison.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Arrhythmias, Cardiac; Atenolol; Defibrillators, Impla | 1998 |
Intravenous beta blockade in acute myocardial infarction. Case for intravenous beta blockade for patients given thrombolysis is still uncertain.
Topics: Adrenergic beta-Antagonists; Chest Pain; Humans; Metoprolol; Myocardial Infarction; Recurrence; Thro | 1999 |
Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Clinical Protocols; Female; Follow-Up Studie | 1999 |
Beta-blocker withdrawal syndrome?
Topics: Angina Pectoris; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Propanolamines; Recur | 1979 |
[A case of repetitive monomorphic ventricular tachycardia].
Topics: Aprindine; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Elec | 1992 |
Safety of combined intravenous beta-adrenergic blockade (atenolol or metoprolol) and thrombolytic therapy in acute myocardial infarction.
Topics: Administration, Oral; Adult; Aspirin; Atenolol; Combined Modality Therapy; Female; Humans; Infusions | 1992 |
[Life threatening syncope in a 69-year-old male: syndrome of hyperactive parasympathetic counter-regulation].
Topics: Aged; Cardiomyopathy, Hypertrophic; Cerebral Hemorrhage; Hemodynamics; Homeostasis; Humans; Isoprote | 1990 |
5-year mortality rate in patients with suspected acute myocardial infarction in relation to early diagnosis.
Topics: Double-Blind Method; Humans; Metoprolol; Myocardial Infarction; Prospective Studies; Random Allocati | 1988 |
[Prevention of reinfarction with beta blockaders: socioeconomic effect of metoprolol treatment].
Topics: Aged; Costs and Cost Analysis; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Recurre | 1986 |